Michael Floyd - 06 Oct 2022 Form 4 Insider Report for Processa Pharmaceuticals, Inc. (PCSA)

Role
Chief Operating Officer
Signature
/s/ Michael Floyd by Michael B. Kirwan, as Attorney-in-Fact
Issuer symbol
PCSA
Transactions as of
06 Oct 2022
Transactions value $
$0
Form type
4
Filing time
11 Oct 2022, 09:35:09 UTC
Previous filing
03 Oct 2022
Next filing
04 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCSA Common Stock Options Exercise +12,500 +19.55% 76,430 06 Oct 2022 Direct F1
transaction PCSA Common Stock Tax liability $0 -4,163 -5.45% $0 72,267 06 Oct 2022 Direct
holding PCSA Common Stock 89,794 06 Oct 2022 by Elion Oncology, Inc.
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Vesting of restricted stock.